MIR3118-4

RNA & survival
SurvivalRNAKaplan–Meier · TCGA cohorts

Across TCGA pan-cancer cohorts, MIR3118-4 RNA is linked to patient survival in 1 of 34 cancer types, making it the most broadly survival-associated MIR3118-4 data layer.

The strongest signal is observed in prostate adenocarcinoma (PRAD), where higher MIR3118-4 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated MIR3118-4 expression acts as an unfavorable survival marker.

PRAD are the cancer types where MIR3118-4 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.
LineageMeasureSplitStageAUC1
high
AUC2
low
pSampling consensus
PRADOSTertileAll0.9610.995.02412view →
Pink = unfavorable, green = favorable. Showing the 1 strongest of 1 lineages.

MIR3118-4–PRAD (OS)

Kaplan–Meier survival curve for MIR3118-4 RNA-high vs -low samples in PRAD.

Open the PRAD breakdown →

Exploration